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A B S T R A C T
Corynebacterium species are increasingly recognized as opportunistic pathogens. A growing number of
taxonomic studies has yielded a description of numerous new Corynebacterium species, such as those
related to the urogenital tract, with Corynebacterium glucuronolyticum found to be rarely involved in
genitourinary tract infections, particularly in male individuals.
In this report, we describe a urethritis case caused by C. glucuronolyticum in a 37-year-old, apparently
healthy male, who complained mild pain in the lower abdomen, with several urinary symptoms. While
urethral and semen specimens did not yield positive results for microbiological evaluation, cultures of
urine samples revealed the monomicrobial growth on blood-containing media of tiny colonies after 24 h
of incubation, clearly evident only after 48 h of incubation under CO2-enriched atmosphere. Colonies
were identiﬁed as C. glucuronolyticum both by matrix-assisted laser desorption ionization-time of ﬂight
(MALDI-TOF) and 16S rRNA gene sequencing. Oral ciproﬂoxacin gradually led to clinical improvement
and, ﬁnally, to a complete recovery, in accordance with microbiological ﬁndings. In spite of its infrequent
detection, C. glucuronolyticum might be a potential urogenital pathogen in males more commonly that
what believed, perhaps due to slow growth leading to underrecognition; we suggest therefore to
consider the organism in the differential diagnostics of bacterial diseases of the urinary tract.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Corynebacterium species, also referred as ‘‘Gram-positive rods’’,
‘‘diphtheroids’’, or ‘‘coryneform bacteria’’, are Gram-positive
bacteria belonging to the genus Corynebacterium, characterized
by a high G + C content, and comprising a collection of aerobically
growing, non-partially-acid-fast, non-sporogenous, irregular rod-
shaped microorganisms [1].
Corynebacterium species are increasingly being recognized as
causing opportunistic diseases under certain predisposing clinical
conditions [2]. The most important pathogen of this genus remains
Corynebacterium diphtheriae, the causative agent of diphtheria, that
has essentially disappeared from developed countries after imple-
mentation of universal vaccination [3]. Corynebacteria have been* Corresponding author at: Centro Integrato di Ricerca (CIR), Laboratory of
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4.0/).also involved in zoonotic infections, as is the case of Corynebacterium
pseudotuberculosis, and Corynebacterium ulcerans, historically
thought to cause disease in patients who consumed contaminated
milk or were close to farm or companion animals [3,4].
A growing number of taxonomic studies have yielded a
description of numerous new Corynebacterium species, such as
those related to the urogenital tract and, in this context, the names
Corynebacterium glucuronolyticum and Corynebacterium seminale
were proposed in 1995 by two independent studies focusing on
isolates mainly recovered from human genitourinary tract [5,6]. It
has been later reported that the presumed two species were indeed
the same one [2], as conﬁrmed by genotypic analyses [7,8]. Because
of earlier description of C. glucuronolyticum [5], nomenclature
priority has been assigned to this species, with C. seminale being
today a synonym.
Case report
A 37-year-old, apparently healthy male without any known
immune deﬁcit presented with lower abdomen mild pain alonge under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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urinating, and frequency, suggestive of prostatitis or urethritis.
Kidney and pelvic ultrasonography did not show, however, any
pathologic alterations either in the mentioned gland or in other
districts of the urinary tract. These ﬁndings, together with the
clinical syndrome referred, were therefore suggestive of urethritis.
Urethral swabs, semen, and urine samples were collected and sent
to laboratory for microbiological evaluation. Pending results, the
patient received empiric ciproﬂoxacin orally, 500 mg every 12 h,
for 10 days. Urethral sampling was performed by inserting and
rotating a dry rayon swab with an aluminum shaft (Copan Italia,
Brescia, Italy) 2 cm into the urethra. A Chlamydia Direct IF (ID)
Assay (bioMe´rieux, Mercy l’Etoile, France) for identiﬁcation of
Chlamydia trachomatis by the direct ﬂuorescent antibody tech-
nique and a Mycoplasma Mycofast US Kit (ELITech France, Signe,
France) for Ureaplasma and Mycoplasma species gave negative
results. Semen specimen examined by wet-mount microscopy did
not show the presence of Trichomonas vaginalis. Both urethral swab
and semen specimens inoculated on Columbia Agar with 5%
deﬁbrinated sheep blood and PVX chocolate agar (Lioﬁlchem,
Roseto degli Abruzzi, Italy) and incubated at 37 8C aerobically and
under 5% CO2 atmosphere were negative. Urine sediment analysis
provided instead evidence for bacteriuria, presence of urinary
esterase, as well as leukocyturia (570 cells/mL).
Urine samples streaked on Columbia Blood Agar, Columbia
Blood Agar supplemented with colistin and nalidixic acid, and
MacConkey agar (Lioﬁlchem) yielded a signiﬁcant growth
(>1  105 CFU/mL), as a pure culture, on blood-containing media
of an organism producing, after 24 h of incubation, tiny, white-
yellow, non-hemolytic colonies of about 1.5 mm of diameter-sized,
that grew better after 48 h of incubation under CO2-enriched
atmosphere. Gram staining revealed Gram-positive bacilli with a
distinctive ‘club-shaped’ arrangement. The colonies were catalase-
positive, identiﬁed as C. glucuronolyticum by MALDI-TOF MS using
Bruker Biotyper software 2.0 (Bruker Daltonics, Germany), with an
excellent score to the species level (score of 2.2). Identiﬁcation was
conﬁrmed by sequencing of a 16S rRNA gene 900-bp amplicon,
analyzed using BLAST (see http://blast.ncbi.nlm.nih.gov/Blast.cgi),
with a BLAST 100% homology with C. glucuronolyticum strain V17
2011556 (GenBank accession no. KF926050.1). Agar disk diffusion
test performed according to the EUCAST 2015 guidelines (www.
eucast.org, last update 26 January 2015) showed susceptibility to
ciproﬂoxacin, penicillin, vancomycin, linezolid, rifampicin, but
resistance to tetracycline, gentamicin, erythromycin, and clinda-
mycin. Accordingly, the abovementioned empirically administered
ﬂuoroquinolone led to complete clinical resolution.
Two months later, the patient was still asymptomatic, and a
follow-up urine sample yielded 50,000 CFU/mL C. glucuronolyti-
cum, with sediment analysis documenting a signiﬁcant decrease of
leukocytes number (50 cells/mL). The patient did not receive any
further treatment and, four months later, a third urine sample was
ﬁnally negative for both bacterial growth and sediment leukocyte
observation.
Discussion
A growing number of infections caused by coryneform bacteria
have been documented in the past years, mainly due to the
increased number of immunocompromised patients, and to a
deeper attention given to both the pathogenic potential and
taxonomy of this bacterial genus. C. glucuronolyticum is a rare
species isolated from male patients with genitourinary tract
infections, probably being part of the normal male genitourinary
microbiota, while its presence in females is uncertain. Uncom-
monly, C. glucuronolyticum has been also found in blood and
peritoneal ﬂuid [5,9], and, recently, it has been recognized amongthe most common agents of monomicrobial paucisymptomatic
bacterial prostatitis, along with coagulase-negative Staphylococcus
spp., and Escherichia coli [10]. Finally, it has been found that C.
glucuronolyticum is not associated exclusively with humans, but
also with animals [7,11].
In this report we documented an episode of urethritis caused by
C. glucuronolyticum, thus further conﬁrming the pathogenic role of
this species in the genitourinary tract infections, mainly in
otherwise healthy males, in agreement with the more recently
published literature [12,13].
Although C. glucuronolyticum is reported to be a non-lipophilic
microorganism, lipophilic Corynebacterium species have been
described to grow poorly in broth or as tiny pinpoint colonies
onto standard agar plates after 24 h-incubation [14]. In this case
the strain grew as tiny colonies after 24 h-incubation under 5% CO2
atmosphere, being more clearly observed only after 48 h of
incubation.
Identiﬁcation of coryneforms to the species level is often
problematic [15]. It should be always performed when they grow
as pure culture from clinical specimens and when they represent
the most abundant organisms in samples collected from physio-
logically sterile sites. Establishing an association between Coryne-
bacterium species and disease is strictly dependent on a correct
identiﬁcation to the species level [16]. In fact, an accurate species
identiﬁcation of this group of bacteria is worthwhile to ascribe
potential pathogenic role to species that were previously thought
to be mere innocent bystanders, and to discriminate infective
agents from harmless colonizers. Therefore, the methods used for
identiﬁcation have to be appropriate and must reﬂect taxonomic
changes observed among coryneform bacteria.
Most coryneform taxa can be identiﬁed to the species level
mainly through three different identiﬁcation approaches, (i)
phenotypic methods, mostly relying on biochemical tests; (ii)
proteomic-based analysis, meaning the use of MALDI-TOF
technology; (iii) sequence-based identiﬁcation methods [17,18].
It is also necessary to emphasize the importance of Gram staining
for the preliminary identiﬁcation of coryneform bacteria [14]. As
regards biochemical tests, the key reactions that are used to
differentiate coryneforms are catalase activity, fermentative or
oxidative carbohydrate utilization, urea production, esculin
hydrolysis, and the CAMP reaction, the latter being obtained by
inoculating a studied isolate perpendicularly to a b-hemolysin-
producing Staphylococcus strain [14,19]. Motility and establishing
whether the isolate is lipophilic are also helpful [14]. MALDI-TOF
represents a revolutionary technology, that rapidly became a
routinely used tool in many microbiology laboratories, whereby
speciﬁc bacterial proteins are ionized and detected by a mass
spectrometer; then the generated spectrum is analyzed, and its
pattern compared to entries found in a database, thus giving rise to
a score matching species-speciﬁc proﬁle.
There are limited studies evaluating the use of MALDI-TOF for
Corynebacterium spp. identiﬁcation, although ﬁndings are com-
forting [20–22]. Molecular genetic techniques for species identiﬁ-
cation of Corynebacterium strains include 16S rRNA gene and rpoB
gene sequencing [14,17]. In this report, C. glucuronolyticum was
correctly and consistently identiﬁed to the species level by using
both MALDI TOF and 16S rRNA gene sequencing, thus conﬁrming
the former as a rapid and valuable system for identiﬁcation of this
species.
C. glucuronolyticum isolates have been frequently shown to be
tetracycline-resistant and may also exhibit resistance to macro-
lides and lincosamides [23]. C. glucuronolyticum strains resistant to
ciproﬂoxacin have been recently described [13]. Our strain
resulted to be resistant, in vitro, to tetracycline, macrolides, and
lincosamides, but susceptible to all other antibiotics tested and,
particularly, the ﬂuoroquinolone proven to be effective to treat the
G. Gherardi et al. / IDCases 2 (2015) 56–5858infectious process described. Although C. glucuronolyticum is
infrequently isolated, we strongly recommend that it should be
considered as a potential cause of urogenital infection in male
patients, and therefore always included in the etiologic diagnostic
algorithm. In particular, the slow growth this species may display
on agar media should be taken into account, as emphasized here, to
reach a reliable diagnosis.
References
[1] Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, Chater KF, et al.
Genomics of Actinobacteria: tracing the evolutionary history of an ancient
phylum. Microbiol Mol Biol Rev 2007;71:495–548.
[2] Funke G, von Graevenitz A, Clarridge J III, Bernard KA. Clinical microbiology of
coryneform bacteria. Clin Microbiol Rev 1997;10:125–59.
[3] Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Efstratiou A.
Diphtheria surveillance network, diphtheria in the postepidemic period, Eur-
ope, 2000–2009. Emerg Infect Dis 2012;18:217–25.
[4] Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in ovine
caseous lymphadenitis. J Comp Pathol 2007;137:179–210.
[5] Funke G, Bernard KA, Bucher C, Pfyffer GE, Collins MD. Corynebacterium
glucuronolyticum sp. nov. isolated from male patients with genitourinary
infections. Med Microbiol Lett 1995;4:204–15.
[6] Riegel P, Ruimy R, de Briel D, Prevost G, Jehl F, Bimet F, et al. Corynebacterium
seminale sp. nov., a new species associated with genital infections in male
patients. J Clin Microbiol 1995;33:2244–9.
[7] Devriese LA, Riegel P, Hommez J, Vaneechoutte M, de Baere T, Haesebrouck F.
Identiﬁcation of Corynebacterium glucuronolyticum strains from the urogenital
tract of humans and pigs. J Clin Microbiol 2000;38:4657–9.
[8] Tanner MA, Shoskes D, Shahed A, Pace NR. Prevalence of corynebacterial 16S
rRNA sequences in patients with bacterial and ‘‘nonbacterial’’ prostatitis. J Clin
Microbiol 1999;37:1863–70.
[9] Bernard KA, Munro C, Wiebe D, Ongsansoy E. Characteristics of rare or recently
described Corynebacterium species recovered from human clinical material in
Canada. J Clin Microbiol 2002;40:4375–81.
[10] Novo-Veleiro I, Herna´ndez-Cabrera M, Can˜as-Herna´ndez F, Pisos-A´lamo E,
France´s-Urmeneta A, Delgado-Yagu¨e M, et al. Paucisymptomatic infectious
prostatitis as a cause of fever without an apparent origin. A series of 19
patients. Eur J Clin Microbiol Infect Dis 2013;32:263–8.[11] Takahashi T, Mori Y, Kobayashi H, Ochi M, Kikuschi N, Hiramune T. Phyloge-
netic positions and assignment of swine and ovine corynebacterial isolates
based on the 16S rRNA sequence. Microbiol Immunol 1997;41:649–55.
[12] Galan-Sanchez F, Aznar-Marin P, Marin-Casanova P, Garcia-Martos P, Rodri-
guez-Iglesias M. Urethritis due to Corynebacterium glucuronolyticum. J Infect
Chemother 2011;17:720–1.
[13] Mesˇtrovic´ T, Bedenic´ B, Ljubin-Sternak S, Sviben M, Profozic´ Z. Ciproﬂoxacin-
resistant Corynebacterium glucuronolyticum as a cause of male urethritis syn-
drome. JMM Case Rep 2014;2:7. http://dx.doi.org/10.1099/jmmcr.0.000208.
[14] Bernard K. The genus Corynebacterium and other medically relevant coryne-
form-like bacteria. J Clin Microbiol 2012;50:3152–8.
[15] Savini V, Gherardi G, Favaro M, Fontana C, Marrollo R, Argentieri AV, et al.
About a bloodstream Corynebacterium striatum isolate. Folia Microbiol (Praha)
2013;58:451–3.
[16] Coyle MB, Lipsk BA. Coryneform bacteria in infectious diseases: clinical and
laboratory aspects. Clin Microbiol Rev 1990;3:227–46.
[17] Khamis A, Raoult D, La Scola B. Comparison between rpoB and 16S rRNA gene
sequencing for molecular identiﬁcation of 168 clinical isolates of Corynebac-
terium. J Clin Microbiol 2005;43:1934–6.
[18] Rennie RP, Brosnikoff C, Turnbull L, Reller LB, Mirrett S, Janda W, et al.
Multicenter evaluation of the Vitek 2 anaerobe and Corynebacterium identiﬁ-
cation card. J Clin Microbiol 2008;46:2646–51.
[19] Savini V, Paparella A, Serio A, Marrollo R, Carretto E, Fazii P. Staphylococcus
pseudintermedius for CAMP-test. Int J Clin Exp Pathol 2014;15(7):1733–4.
[20] Alatoom AA, Cazanave CJ, Cunningham SA, Ihde SM, Patel R. Identiﬁcation
of non-diphtheriae Corynebacterium by use of matrix-assisted laser de-
sorption ionization-time of ﬂight mass spectrometry. J Clin Microbiol
2012;50:160–3.
[21] Konrad R, Berger A, Huber I, Boschert V, Ho¨rmansdorfer S, Busch U, et al.
Matrix-assisted laser desorption/ionisation time of ﬂight (MALDI-TOF) mass
spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebac-
terium species in the laboratory management of diphtheria-associated bacte-
ria. Euro Surveill 2010;15. pii:19699.
[22] Vila J, Juiz P, Salas C, Almela M, de la Fuente CG, Zboromyrska Y, et al.
Identiﬁcation of clinically relevant Corynebacterium spp., Arcanobacterium
haemolyticum, and Rhodococcus equi by matrix-assisted laser desorption
ionization-time of ﬂight mass spectrometry. J Clin Microbiol 2012;50:
1745–7.
[23] Funke G, Pu¨nter V, von Graevenitz A. Antimicrobial susceptibility patterns of
some recently established coryneform bacteria. Antimicrob Agents Che-
mother 1996;40:2874–8.
